Clinical Trial Update: Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating standard of care with or without Ad-CEA vaccine and avelumab in previously untreated metastatic colorectal cancer; trial termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasms

Drugs mentioned

• Ad-CEA vaccine (CEA vaccine)
• Avelumab (avelumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Tumors, Colorectal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2021-12-09